(1)
Russo, I.; Cazzolla, S.; Pampaloni, F.; Alaibac, M. Omalizumab for the Treatment of Chronic Spontaneous Urticaria: Association Between Body Mass Index and Outcome. Dermatol Pract Concept 2022, 12 (4), e2022148. https://doi.org/10.5826/dpc.1204a148.